by The fme Team | Jun 3, 2022 | Content Migration, Enterprise Content Management, Life Sciences
For validated content used in submissions, even 95% extraction accuracy is too risky. For a whole host of strategic and business efficiency reasons, not to mention compliance drivers (including preparation for the EU’s implementation of IDMP), most pharmaceutical...
by The fme Team | Apr 28, 2022 | Digital Transformation, Enterprise Content Management, Further Industries, Industrial Manufacturing, Life Sciences
Even with the best intentions, companies will only be able to deliver successful global data transformation projects if they have strong global teams pulling together toward the same goal. But what does that look like, especially when so many restrictions on travel...
by The fme Team | Apr 5, 2022 | Content Migration, Digital Transformation, Enterprise Content Management, Further Industries, Industrial Manufacturing, Life Sciences
There could be a whole range of requirements which have led to the decision to implement a new content or document management system (DMS), but a successful project will depend as much on defining what you don’t need as it will on specifying what’s most important....
by The fme Team | Mar 25, 2022 | Content Migration, Digital Transformation, Enterprise Content Management, Life Sciences
Without top-grade data, even the most innovative life sciences company in the world will struggle to realize its potential. That’s because, without robust, reliable and well-maintained information, formatted in a consistent and agreed way that’s acceptable to...
by The fme Team | Mar 1, 2022 | Content Migration, Digital Transformation, Enterprise Content Management, Life Sciences
Improved dynamism is now a strategic priority in life sciences. The Covid-19 response has seen a radical transformation of the drug development and approval process – reducing cycles that once spanned 10 years to a matter of months. Going forward, pressure on...
by The fme Team | Aug 20, 2021 | Business Consulting, Life Sciences
Historically, clinical outsourcing has negated the need for small-to-midsize Sponsors to maintain their own in-house Clinical Trial Management System (CTMS) application. With the evolution of adaptive protocol design and the increased importance of capturing,...
